in proportion to their current shareholdings, provided that such shareholder names appear on the Record Date as at May 3, 2018. The offering ratio shall be 1 existing ordinary share to 1 newly issued
Net Profit/3 604.5 340.6 (263.8) (43.6%) /1 Including other income and share of profit from investments in associates and JVs /2 Gross profit including share of profit from investments in associates and
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
(Translation) — 1 — (Translation) No. 10000000/ 152 /61 20 June 2018 Subject: Resolutions passed by the Board of Directors Meeting regarding the share acquisition, the tender offer for the entire
newly issued preferred shares, with a par value of Baht 1 per share, at an offering price of Baht 0.031 per share, totaling Baht 2,172 million, and (2) Bangkok Bank Public Company Limited (“BBL”) in the
of dividend, schedule of Annual General Meeting of Shareholder for the year 2019, capital increase by allocating via general mandate, an increasing of investment cost in Carnival Magic Project, and
Meeting regarding no payment of dividend, schedule of Annual General Meeting of Shareholder for the year 2019, capital increase by allocating via general mandate, an increasing of investment cost in
share-Owners of the Company (0.10 ) (0.07 ) (0.03) (40.56%) Attributable to Owners of the Company (84.18) (59.89) (24.29 ) (40.56%) Non-controlling interests - - - - 1. Operating revenue In summary
December 2019 for an additional 0.04 baht per share, which was the dividend from the profit exempted from corporate income tax, amounting to 12,000,013.60 baht. The Company will identify rightful
and employee benefit obligations by 1.8 MB. Shareholders' Equity As of June 30, 2019, the Company and its subsidiaries had total shareholder equity of 410.1 MB which increased from December 31, 2018